The latest molecular studies have presented many insights in to the processes that govern the development and progression of CLL, like quite a few novel mutated genes clustered in various purposeful pathways. The CLL epigenome is reprogrammed through the modulation of regulatory regions that appear de novo in the condition, While other locations pr